Open AccessA Trial of a Shorter Regimen for Rifampin-Resistant Tuberculosis
Author(s) -
Andrew Nunn,
Patrick Phillips,
Sarah Meredith,
ChenYuan Chiang,
Francesca Conradie,
D. Dalai,
Armand Van Deun,
Phan-Thuong Dat,
Ngoc Lan,
Iqbal Master,
Tesfamarium Mebrahtu,
Daniel Meressa,
Ronelle Moodliar,
Nosipho Ngubane,
Karen Sanders,
S. Bertel Squire,
Gabriela Torrea,
Bazarragchaa Tsogt,
I. D. Rusen
Publication year - 2019
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1811867
Subject(s) - regimen , tuberculosis , medicine , pathology
Cohort studies in Bangladesh showed promising cure rates among patients with multidrug-resistant tuberculosis who received existing drugs in regimens shorter than that recommended by the World Health Organization (WHO) in 2011.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom